dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Pinato, David J. |
dc.contributor.author | Murray, Sam M |
dc.contributor.author | Forner, Alejandro |
dc.contributor.author | Kaneko, Takahiro |
dc.contributor.author | Fessas, Petros |
dc.contributor.author | Toniutto, Pierluigi |
dc.contributor.author | Minguez Rosique, Beatriz |
dc.date.accessioned | 2022-05-02T13:16:26Z |
dc.date.available | 2022-05-02T13:16:26Z |
dc.date.issued | 2021-09-30 |
dc.identifier.citation | Pinato DJ, Murray SM, Forner A, Kaneko T, Fessas P, Toniutto P, et al. Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy. J Immunother Cancer. 2021 Sep 30;9(9):e003311. |
dc.identifier.issn | 2051-1426 |
dc.identifier.uri | https://hdl.handle.net/11351/7455 |
dc.description | Immunoteràpia; Neoplàsies hepàtiques |
dc.description.sponsorship | DJP is supported by grant funding from the Wellcome Trust Strategic Fund (PS3416) and by the Cancer Research UK Postdoctoral bursary (C57701/A26137). AF is supported by grant from Instituto de Salud Carlos III (PI18/00542). |
dc.language.iso | eng |
dc.publisher | BMJ |
dc.relation.ispartofseries | Journal for ImmunoTherapy of Cancer;9(9) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Fetge - Càncer - Tractament |
dc.subject | Hemostàtics |
dc.subject | Mort cel·lular |
dc.subject.mesh | Chemoembolization, Therapeutic |
dc.subject.mesh | Carcinoma, Hepatocellular |
dc.subject.mesh | /drug therapy |
dc.title | Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1136/jitc-2021-003311 |
dc.subject.decs | quimioembolización terapéutica |
dc.subject.decs | carcinoma hepatocelular |
dc.subject.decs | /farmacoterapia |
dc.relation.publishversion | http://dx.doi.org/10.1136/jitc-2021-003311 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Pinato DJ] Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK. Division of Oncology, Department of Translational Medicine, Universita del Piemonte Orientale "A. Avogadro", Novara, Italy. [Murray SM] Department of Infectious Diseases, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK. [Forner A] Liver Unit, Barcelona Clinic Liver Cancer (BCLC) Group, University of Barcelona, Hospital Clinic, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain. [Kaneko T] Tokyo Medical and Dental University, Bunkyo-ku, Japan. [Fessas P] Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK. [Toniutto P] Hepatology and Liver Transplantation Unit, Department of Medical Area (DAME), University of Udine, Udine, Italy. [Mínguez B] Unitat del Fetge, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 34593621 |
dc.identifier.wos | 000703191800004 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |